Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer

Published:2021-06-28 Issue:6 Volume:4 Page:e2114162
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Graf Ryon P.¹²,Eskander Ramez¹,Brueggeman Leo³⁴,Stupack Dwayne G.¹

Affiliation:

1. Moores Cancer Center, University of California, San Diego

2. Now at Foundation Medicine Inc, Cambridge, Massachusetts

3. Interdisciplinary Genetics Program, University of Iowa, Iowa City

4. Medical Scientist Training Program, University of Iowa, Iowa City

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2781458/graf_2021_oi_210428_1633450173.89598.pdf

Reference29 articles.

1. Cancer statistics, 2018.;Siegel;CA Cancer J Clin,2018

2. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer.;Ray-Coquard;N Engl J Med,2019

3. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer.;Coleman;N Engl J Med,2019

4. Niraparib in patients with newly diagnosed advanced ovarian cancer.;González-Martín;N Engl J Med,2019

5. Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer.;Tewari;J Clin Oncol,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer;International Journal of Molecular Sciences;2024-04-28

2. Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer;PLOS ONE;2024-02-12

3. A deep-learning-based genomic status estimating framework for homologous recombination deficiency detection from low-pass whole genome sequencing;Heliyon;2024-02

4. Evolutionary mode and timing of dissemination of high-grade serous carcinomas;JCI Insight;2024-01-04

5. Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer;Cancer Communications;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3